PURPLE BIOTECH LTD. - PPBT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$547K
QoQ value delta ($000)
+$474K (+649.32%)
Implied price effect (QoQ)
+18.1%
Shares
Total shares
841,616
QoQ shares delta
+708,967 (+534.47%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PPBT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP 308 469,767 0.0%
TWO SIGMA INVESTMENTS, LP 102 155,353 0.0%
CITADEL ADVISORS LLC 67 102,737 0.0%
SmartHarvest Portfolios, LLC 31 47,454 0.01%
BNP PARIBAS FINANCIAL MARKETS 13 21,075 0.0%
TWO SIGMA ADVISERS, LP 9 14,700 0.0%
SIMPLEX TRADING, LLC 6 9,231 0.0%
MORGAN STANLEY 4 6,091 0.0%
RHUMBLINE ADVISERS 4 7,392 0.0%
UBS Group AG 2 3,098 0.0%
GAMMA Investing LLC 1 2,836 0.0%
JONES FINANCIAL COMPANIES LLLP 0 50 0.0%
GROUP ONE TRADING LLC 0 1,294 0.0%
ROYAL BANK OF CANADA 0 107 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0 85 0.0%
Tradewinds Capital Management, LLC 0 10 0.0%
Global Retirement Partners, LLC 0 16 0.0%
SBI Securities Co., Ltd. 0 320 0.0%